SCHEMBL634183

SCHEMBL634183

CCCCCCNS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.72

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 13/20 0.72
CA12 O43570 1/20 0.64
CA2 P00918 1/20 0.64
CA9 Q16790 1/20 0.64
HTT P42858 2/20 0.62
ALOX15 P16050 1/20 0.62
LMNA P02545 4/20 0.61
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
MAPK1 P28482 1/20 0.60
PKM P14618 3/20 0.59
KDM4E B2RXH2 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
MBTD1 Q05BQ5 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
GAA P10253 1/20 0.56
MAPT P10636 1/20 0.56
ALOX12 P18054 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL635949 1.00 ALDH1A1 (0.72) ALDH1A1CA12CA2CA9HTT
SCHEMBL633648 1.00 ALDH1A1 (0.72) ALDH1A1CA12CA2CA9HTT
SCHEMBL28034898 1.00 ALDH1A1 (0.72) ALDH1A1CA12CA2CA9HTT
SCHEMBL634180 1.00 ALDH1A1 (0.72) ALDH1A1CA12CA2CA9HTT
SCHEMBL8355315 1.00 ALDH1A1 (0.72) ALDH1A1CA12CA2CA9HTT
SCHEMBL5696735 1.00 ALDH1A1 (0.72) ALDH1A1CA12CA2CA9HTT
SCHEMBL7103280 1.00 ALDH1A1 (0.72) ALDH1A1CA12CA2CA9HTT
SCHEMBL223156 1.00 ALDH1A1 (0.72) ALDH1A1CA12CA2CA9HTT
SCHEMBL635208 0.98 ALDH1A1 (0.70) ALDH1A1CA12CA2CA9HTT
SCHEMBL187922 0.93 ALDH1A1 (0.72) ALDH1A1CA12CA2CA9HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105778017-A Preparation method of building concrete water reducing agent 河南工程学院 2016-07-20 CN claimed
US-20140073801-A1 PYRROLIDINE DERIVATIVES AS SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF SUMMIT CORPORATION PLC (GB) 2014-03-13 US claimed
EP-2681190-A1 PYRROLIDINE DERIVATIVES AS SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF Summit Corporation Plc (GB) 2014-01-08 EP claimed
WO-2012117219-A1 PYRROLIDINE DERIVATIVES AS SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF SUMMIT CORPORATION PLC (GB) 2012-09-07 WO claimed
EP-3893054-B1 PATTERN FORMING METHOD, PHOTOSENSITIVE RESIN COMPOSITION, CURED FILM, LAMINATE, AND DEVICE FUJIFILM CORP (JP) 2026-05-06 EP disclosed
US-12559592-B2 Branched amorphous polyamide (co)polymers and methods of making and using same 3M INNOVATIVE PROPERTIES COMPANY (US) 2026-02-24 US disclosed
US-12393116-B2 Pattern forming method, photosensitive resin composition, cured film, laminate, and device FUJIFILM CORPORATION (JP) 2025-08-19 US disclosed
EP-3893053-B1 PHOTOSENSITIVE RESIN COMPOSITION, PATTERN FORMING METHOD, CURED FILM, MULTILAYER BODY AND DEVICE FUJIFILM CORP (JP) 2025-01-22 EP disclosed
CN-115003756-B Resin composition 松下知识产权经营株式会社 2024-10-01 CN disclosed
US-12078929-B2 Photosensitive resin composition, pattern forming method, cured film, laminate, and device FUJIFILM CORPORATION (JP) 2024-09-03 US disclosed
US-20230167243-A1 BRANCHED AMORPHOUS POLYAMIDE (CO)POLYMERS AND METHODS OF MAKING AND USING SAME 3M INNOVATIVE PROPERTIES COMPANY 2023-06-01 US disclosed
CN-115427532-A Branched amorphous polyamide (co) polymers and methods of making and using the same 3M创新有限公司 2022-12-02 CN disclosed
EP-2088173-A1 CURABLE COMPOSITION AND CATALYST COMPOSITION Kaneka Corporation (JP) 2009-08-12 EP disclosed
EP-1632364-A1 Pneumatic tire Sumitomo Rubber Industries, Ltd. (JP) 2006-03-08 EP disclosed
US-5922443-A Polymeric article, such as a medical catheter, and method for making the same BOSTON SCIENTIFIC GLENS FALLS CORP. 1999-07-13 US disclosed
EP-0514913-B1 A polymeric article, such as a medical catheter, and method for making the same NAMIC CARIBE INC (PR) 1997-03-12 EP disclosed
US-5484565-A Method for making a medical catheter NAMIC CARIBE, INC. (PR) 1996-01-16 US disclosed
EP-0514913-A2 A polymeric article, such as a medical catheter, and method for making the same NAMIC CARIBE, INC. (PR) 1992-11-25 EP disclosed
US-4053458-A INHIBITORS UOP INC. (US) 1977-10-11 US disclosed
US-4022828-A BIS-(SULFONAMIDO)-SULFIDES UNIVERSAL OIL PRODUCTS COMPANY (US) 1977-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140073801-A1 PYRROLIDINE DERIVATIVES AS SELECTIVE GLYCOSIDASE INHIBITORS AND USES THEREOF OGA, GAA, GBA3 ALDH1A1 958/4885CA12 870/4885CA2 688/4885
US-12559592-B2 Branched amorphous polyamide (co)polymers and methods of making and using same COL2A1, PARG, COL1A1 ALDH1A1 1929/4885CA12 2104/4885CA2 617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.